Home Newsfeeds Needham Reiterates Buy on Microchip Technology, Maintains $110 Price Target

Needham Reiterates Buy on Microchip Technology, Maintains $110 Price Target

Needham analyst Rajvindra Gill reiterates Microchip Technology (NASDAQ:MCHP) with a Buy and maintains $110 price target.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Needham analyst Rajvindra Gill reiterates Microchip Technology (NASDAQ:MCHP) with a Buy and maintains $110 price target.

News

‘GeForce NOW Update Delivers Stunning Visuals To Android Devices’ – Nvidia

By Benzinga Newsdesk

January 25, 10:11 AM

https://blogs.nvidia.com/blog/geforce-now-thursday-android-higher-resolutions/GeForce NOW transforms nearly any device into a high-powered PC gaming rig, and members streaming on Android can now access that power from

NVDA

Li-Cycle Holdings Q3 Revenue From Product Sales And Recycling Services $5.4M

By Bill Haddad

September 14, 6:05 AM

Li-Cycle Holdings Corp. (NYSE:LICY) ("Li-Cycle" or the "Company"), an industry leader in lithium-ion battery resource recovery and the leading lithium-ion battery recycler in North America, today

LICY

Publication Of Data From Adaptimmune’s Completed Phase 1 Trial With Afami-cel In Nature Medicine Demonstrating An Acceptable Safety Profile And Encouraging Responses In Synovial Sarcoma

By Benzinga Newsdesk

January 9, 9:24 AM

-The response rate was 44% in patients with late-stage, metastatic synovial sarcoma after a single dose of afami-cel - - Based on these results, the Company initiated a Phase 2 trial with afami-cel for people

ADAP